Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSEâ„¢ Platform for the treatment of drug ...
Cadrenal Therapeutics, Inc., (the "Company" or "Cadrenal"), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) designed to provide safer and superior ...
England take on Australia for the first time in over two years in the second of their Autumn Nations Series matches this November. England lost their opening game, beaten 22-24 by New Zealand.All ...